Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CRVSCRVS
Showing 8 of 25 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CORVUS PHARMACEUTICALS INC

CITADEL ADVISORS LLC holds 397,951 shares of CRVS (CORVUS PHARMACEUTICALS INC), worth $5.9M as of 2026-Q2. The position was decreased (-10.1% shares). CRVS represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$5.9M

Current Shares

397,951

Total Value Change

+$5.4M

Total Shares Change

+300,878

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
397,951
-10.1%
$5.9M0.0%$14.94
0
2026-Q1
Increased
442,522
+112.6%
$6.5M0.0%$17.53
44
2025-Q4
Increased
208,182
+386.8%
$1.6M0.0%$7.49
41
2025-Q3
New
42,766
-
$315,1850.0%$7.28
36
2025-Q2
Exited
0
-100.0%
$00.0%$3.89
0
2025-Q1
Decreased
61,676
-21.6%
$196,1300.0%$3.38
0
2024-Q4
Decreased
78,712
-18.9%
$421,1090.0%$5.25
0
2024-Q3
Increased
97,073
+83.1%
$512,5450.0%$5.15
37

Other major holders of CRVS: BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used